Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.5900
- TODAY'S CHANGE (%)0.2500 (3.4060%)
- Bid / Lots7.3700/ 13
- Ask / Lots7.6600/ 17
- Open / Previous Close7.3400 / 7.3400
- Day Range
- 52 Week Range
- Volume689,067
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 3067 | 7.34 |
| 09:34 ET | 1025 | 7.36 |
| 09:36 ET | 2900 | 7.4 |
| 09:38 ET | 800 | 7.35 |
| 09:39 ET | 1100 | 7.39 |
| 09:41 ET | 335 | 7.39 |
| 09:43 ET | 24585 | 7.4 |
| 09:45 ET | 200 | 7.405 |
| 09:48 ET | 2200 | 7.39 |
| 09:50 ET | 271 | 7.375 |
| 09:52 ET | 200 | 7.37 |
| 09:54 ET | 400 | 7.39 |
| 09:56 ET | 975 | 7.38 |
| 09:57 ET | 300 | 7.364 |
| 09:59 ET | 100 | 7.36 |
| 10:01 ET | 900 | 7.37 |
| 10:03 ET | 225 | 7.38 |
| 10:06 ET | 700 | 7.4 |
| 10:08 ET | 721 | 7.41 |
| 10:12 ET | 900 | 7.409 |
| 10:14 ET | 11730 | 7.41 |
| 10:15 ET | 5047 | 7.41 |
| 10:17 ET | 14671 | 7.38 |
| 10:19 ET | 2450 | 7.36 |
| 10:21 ET | 900 | 7.35 |
| 10:24 ET | 627 | 7.35 |
| 10:26 ET | 600 | 7.36 |
| 10:30 ET | 900 | 7.35 |
| 10:32 ET | 700 | 7.34 |
| 10:33 ET | 600 | 7.35 |
| 10:35 ET | 672 | 7.35 |
| 10:37 ET | 522 | 7.37 |
| 10:39 ET | 265 | 7.38 |
| 10:44 ET | 700 | 7.4 |
| 10:46 ET | 301 | 7.39 |
| 10:50 ET | 400 | 7.38 |
| 10:51 ET | 929 | 7.38 |
| 10:53 ET | 528 | 7.39 |
| 10:55 ET | 400 | 7.39 |
| 11:02 ET | 100 | 7.39 |
| 11:06 ET | 705 | 7.41 |
| 11:08 ET | 400 | 7.41 |
| 11:11 ET | 2600 | 7.43 |
| 11:13 ET | 1800 | 7.43 |
| 11:15 ET | 1100 | 7.44 |
| 11:18 ET | 4300 | 7.44 |
| 11:20 ET | 1045 | 7.425 |
| 11:22 ET | 600 | 7.44 |
| 11:27 ET | 207 | 7.46 |
| 11:29 ET | 2355 | 7.48 |
| 11:31 ET | 100 | 7.465 |
| 11:33 ET | 1300 | 7.48 |
| 11:36 ET | 100 | 7.49 |
| 11:38 ET | 2373 | 7.515 |
| 11:40 ET | 100 | 7.515 |
| 11:42 ET | 30854 | 7.57 |
| 11:44 ET | 14667 | 7.58 |
| 11:45 ET | 10500 | 7.58 |
| 11:47 ET | 1558 | 7.585 |
| 11:49 ET | 19550 | 7.6 |
| 11:51 ET | 700 | 7.6 |
| 11:56 ET | 300 | 7.61 |
| 11:58 ET | 2192 | 7.61 |
| 12:00 ET | 996 | 7.625 |
| 12:02 ET | 3672 | 7.63 |
| 12:03 ET | 100 | 7.63 |
| 12:05 ET | 200 | 7.64 |
| 12:07 ET | 9474 | 7.58 |
| 12:09 ET | 1317 | 7.57 |
| 12:12 ET | 2052 | 7.585 |
| 12:14 ET | 100 | 7.585 |
| 12:16 ET | 987 | 7.585 |
| 12:18 ET | 200 | 7.59 |
| 12:20 ET | 300 | 7.6 |
| 12:23 ET | 2749 | 7.59 |
| 12:25 ET | 300 | 7.59 |
| 12:30 ET | 800 | 7.59 |
| 12:32 ET | 300 | 7.585 |
| 12:34 ET | 1457 | 7.57 |
| 12:36 ET | 200 | 7.58 |
| 12:38 ET | 441 | 7.57 |
| 12:39 ET | 100 | 7.565 |
| 12:41 ET | 2791 | 7.56 |
| 12:43 ET | 3100 | 7.565 |
| 12:45 ET | 100 | 7.565 |
| 12:48 ET | 521 | 7.56 |
| 12:50 ET | 100 | 7.555 |
| 12:52 ET | 632 | 7.565 |
| 12:54 ET | 3600 | 7.57 |
| 12:56 ET | 100 | 7.55 |
| 12:57 ET | 200 | 7.55 |
| 12:59 ET | 1750 | 7.56 |
| 01:01 ET | 2366 | 7.53 |
| 01:03 ET | 600 | 7.525 |
| 01:06 ET | 1134 | 7.53 |
| 01:08 ET | 1977 | 7.52 |
| 01:10 ET | 300 | 7.54 |
| 01:14 ET | 1674 | 7.545 |
| 01:15 ET | 600 | 7.54 |
| 01:17 ET | 410 | 7.54 |
| 01:19 ET | 300 | 7.535 |
| 01:21 ET | 1355 | 7.55 |
| 01:24 ET | 1496 | 7.57 |
| 01:26 ET | 600 | 7.58 |
| 01:28 ET | 100 | 7.58 |
| 01:30 ET | 888 | 7.58 |
| 01:32 ET | 200 | 7.59 |
| 01:33 ET | 6722 | 7.595 |
| 01:37 ET | 1567 | 7.61 |
| 01:39 ET | 1363 | 7.6 |
| 01:42 ET | 500 | 7.6 |
| 01:44 ET | 1627 | 7.59 |
| 01:46 ET | 919 | 7.57 |
| 01:48 ET | 500 | 7.57 |
| 01:50 ET | 1110 | 7.58 |
| 01:51 ET | 1023 | 7.57 |
| 01:53 ET | 1000 | 7.56 |
| 01:57 ET | 400 | 7.575 |
| 02:00 ET | 200 | 7.57 |
| 02:04 ET | 300 | 7.57 |
| 02:06 ET | 200 | 7.57 |
| 02:08 ET | 860 | 7.56 |
| 02:09 ET | 150 | 7.57 |
| 02:13 ET | 2565 | 7.55 |
| 02:15 ET | 280 | 7.5555 |
| 02:18 ET | 610 | 7.55 |
| 02:20 ET | 2700 | 7.55 |
| 02:22 ET | 425 | 7.55 |
| 02:24 ET | 100 | 7.55 |
| 02:26 ET | 746 | 7.56 |
| 02:27 ET | 500 | 7.57 |
| 02:29 ET | 1400 | 7.56 |
| 02:31 ET | 100 | 7.56 |
| 02:33 ET | 287 | 7.56 |
| 02:38 ET | 619 | 7.5516 |
| 02:40 ET | 300 | 7.56 |
| 02:42 ET | 1451 | 7.57 |
| 02:44 ET | 100 | 7.565 |
| 02:45 ET | 300 | 7.57 |
| 02:49 ET | 296 | 7.59 |
| 02:54 ET | 800 | 7.595 |
| 02:56 ET | 1362 | 7.58 |
| 02:58 ET | 900 | 7.59 |
| 03:00 ET | 767 | 7.58 |
| 03:02 ET | 400 | 7.57 |
| 03:03 ET | 3911 | 7.59 |
| 03:07 ET | 1511 | 7.585 |
| 03:09 ET | 1403 | 7.6 |
| 03:12 ET | 10600 | 7.6 |
| 03:14 ET | 100 | 7.59 |
| 03:16 ET | 851 | 7.6 |
| 03:18 ET | 1093 | 7.6 |
| 03:20 ET | 5607 | 7.595 |
| 03:21 ET | 2805 | 7.61 |
| 03:23 ET | 11670 | 7.6 |
| 03:25 ET | 1318 | 7.58 |
| 03:27 ET | 204 | 7.59 |
| 03:30 ET | 2100 | 7.591 |
| 03:32 ET | 3775 | 7.585 |
| 03:34 ET | 6158 | 7.59 |
| 03:36 ET | 8396 | 7.59 |
| 03:38 ET | 707 | 7.585 |
| 03:39 ET | 326 | 7.59 |
| 03:41 ET | 1100 | 7.585 |
| 03:43 ET | 816 | 7.59 |
| 03:45 ET | 3580 | 7.58 |
| 03:48 ET | 1635 | 7.58 |
| 03:50 ET | 938 | 7.575 |
| 03:52 ET | 8484 | 7.575 |
| 03:54 ET | 10175 | 7.59 |
| 03:56 ET | 9576 | 7.59 |
| 03:57 ET | 18077 | 7.565 |
| 03:59 ET | 152538 | 7.59 |
Oct 3, 2024
Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference, from 4:00PM ET on Thursday Oct 03, 2024 by Dow Jones
4:00PM ET on Thursday Oct 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.0B | -2.1x | --- |
Prothena Corporation PLC | 926.1M | -17.1x | --- |
Immatics NV | 963.0M | -10.3x | --- |
Zymeworks Inc | 937.8M | -8.7x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -4.5x | --- |
Gyre Therapeutics Inc | 1.2B | -15.3x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Chief Financial Officer, Executive Vice President
- Jason O'byrne
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 13.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
